Advanced Search | View Cart | Check Out | 800.633.4743
Bookmark and Share

The Medical Management of HIV/AIDS

The University of California, San Francisco School of Medicine

Order Today and Save 50%!

The Medical Management of HIV/AIDS provides the active intermediate to advanced HIV clinician with a comprehensive review of the science and application of HIV therapy.

Lectures are presented by a group of leading clinicians and researchers who are also dedicated to teaching in their area of expertise. Topics include current dilemmas in antiretroviral therapy, post exposure prophylaxis, common metabolic and drug toxicities, as well as HIV/HCV/HBV co-infection.


 
CREDITS N/A
CE RELEASE N/A
CE EXPIRE N/A
 
Item No Media (Can't decide on a format?) Price Purchase
 
Special pricing for group subscriptions/purchases, contact Harriet Schnoll at 800-253-1053. For customer service call 800-633-4743.
 

Intended Audience


The Medical Management of HIV/AIDS multimedia program is well designed for practicing HIV clinicians including internists, family practitioners, infectious disease specialists, nurse practitioners, and physician assistants.
 
 

Topics & Speakers


Top Ten Stories of HIV Medicine 2007
Diane V. Havlir, MD
Meg D. Newman, MD

Global Prevention in 2007
Nancy Padlan, MD

Deciphering HIV Pathogenesis
Warner Greene, MD, PhD

Antiretrovirals in Development: New Drugs,
New Classes, New Challenges
C. Bradley Hare, MD

HIV Drug Resistance Update
Harry Lampiris, MD

What’s New in HIV Dermatology
Toby Maurer, MD

Hepatitis B / HIV Co-infection
Annie Luetkemeyer, MD

Dilemmas in HIV and
Hepatitis C Management

C. Bradley Hare, MD

Hepatitis Co-Infection Panel
Annie Luetkemeyer, MD
C. Bradley Hare, MD

Metabolic Complications in the HAART Era
Morris Schambelan, MD

International Track Part 2
–– Malaria and HIV

Philip J. Rosenthal, MD

HIV-Associated Pulmonary Disease:
Classic and
Challenging Cases
for the Clinician

Laurence Huang, MD


Cases in ARV Resistance
Jason Tokumoto, MD

Women and HIV: A Case Based Approach
Monica Gandhi, MD, MPH

MRSA in Clinical Care
Lisa G. Winston, MD

STD Management for the HIV
Care Provider: What’s New in the
CDC 2006 STD Treatment Guidelines
Gail Bolan, MD

Acute HIV
Christopher Pilcher, MD

Post Exposure Prophylaxis in 2007
Amy Kindrick, MD, MPH

Psychiatry and HIV
Dan Karasic, MD

Anal Dysplasia in HIV Positive
Men and Women: An Update
Joel M. Palefsky, MD

Update in HIV-Related Renal Disease
Andy Choi, MD

HIV Neurological Disease
Cheryl Jay, MD

Methamphetamine and Club Drugs
Grant Colfax, MD
FACULTY
Course Directors
Diane V. Havlir, MD
Professor of Medicine
Chief, HIV/AIDS Division
Director, Positive Health Program
San Francisco General Hospital
University of California, San Francisco
Meg D. Newman, MD
Associate Professor of Clinical Medicine
Director, PHP-HIV Clinical Scholars Program
Positive Health Program
San Francisco General Hospital
University of California, San Francisco


COURSE FACULTY
(University of California, San Francisco,
School of Medicine unless otherwise noted.)
Gail Bolan, MD
Assistant Clinical Professor of Medicine
Chief, STD Control Branch
California Department of Health Services,
Berkeley


Andy Choi, MD
Adjunct Instructor of Nephrology

Grant Colfax, MD
Director of HIV Prevention and
Research at SFDPH


Monica Gandhi, MD, MPH
Assistant Professor of Medicine
Division of Infectious Disease


Warner Greene, MD, PhD
Director, Gladstone Institute of
Virology and Immunology

Professor of Medicine
Microbiology and Immunology

Co-Director, UCSF-GIVI Center for
AIDS Research


C. Bradley Hare, MD
Assistant Clinical Professor
Positive Health Program, SFGH


Laurence Huang, MD
Associate Professor of Clinical Medicine
Chief, AIDS Chest Clinic, SFGH

Cheryl Jay, MD
Clinical Professor of Neurology

Dan Karasic, MD
Associate Clinical Professor of Psychiatry
Attending Psychiatrist for AIDS Care, SFGH

Amy Kindrick, MD, MPH
Senior Consultant,
National HIV/AIDS Clinicians’

Consultation Center; Associate Physician,
Department of Family and
Community Medicine
Harry Lampiris, MD
Associate Professor of Clinical Medicine
Infectious Disease Section
Department of Medicine

San Francisco VA Medical Center

Annie Luetkemeyer, MD
Clinical Fellow
Positive Health Program, SFGH


Toby Maurer, MD
Associate Professor of Dermatology

Joel M. Palefsky, MD
Professor of Medicine
Division of Infectious Disease


Christopher D. Pilcher, MD
Associate Professor in Residence
Attending Physician, Positive Health Practice, SFGH


Philip J. Rosenthal, MD
Professor of Medicine
Division of Infectious Disease


Morris Schambelan, MD
Associate Chair for Clinical and
Translational Research

Program Director, CTSI Clinical
Research Center


Jason Tokumoto, MD
Assistant Clinical Professor of Medicine

Lisa G. Winston
Assistant Clinical Professor of Medicine
Division of Infectious Disease, SFGH

 
 

Learning Objectives


At the conclusion of this Medical Management of HIV/AIDS multimedia program, participants will be able to discuss:
  • Recent changes in the epidemiology of AIDS nationally and globally
  • New developments in the understanding of HIV pathogenesis
  • Antiretroviral resistance and current strategies for salvage therapy
  • Current recommendations for the management of occupational and sexual post exposure
    prophylaxis (PEP), HCV and/or HBV co-infection with HIV
  • New developments in HIV-related dermatologic, pulmonary, HIV transplant, HIV-Related renal,
    neurological, and psychiatric disease

 
 

Accreditation Statement


The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 
 
 

Faculty Disclosure


Faculty for UCSF’s Continuing Medical Education Program must complete a Declaration of Disclosure prior to the CME activity. Having an interest in or affiliation with a commercial entity does not preclude making a presentation at a CME activity, but the relationship must be disclosed in advance and any potential conflict of interest must be resolved in accordance with the ACCME Updated Standards for Commercial Support. Disclosure must be conveyed to the learning audience prior to the educational offering; presentation of information on investigational/off-label use of pharmaceuticals or medical devices must also be disclosed. Full disclosure of faculty is listed in the syllabus.